AirSculpt Technologies, Inc. Revenue
AirSculpt Technologies, Inc. (AIRS) reported Revenue of $42.90 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Income Statement
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax · last filed 2026-08-10
- AirSculpt Technologies, Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2026-06-30 was $42.90M, a 2.53% decline year-over-year.
- AirSculpt Technologies, Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2026-03-31 was $39.39M, a 0.05% increase year-over-year.
- AirSculpt Technologies, Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2025-12-31 was $33.44M, a 14.64% decline year-over-year.
- AirSculpt Technologies, Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2025-09-30 was $34.99M, a 17.76% decline year-over-year.
- AirSculpt Technologies, Inc. revenue from contract with customer, excluding assessed tax for fiscal 2025 was $151.82M, a 15.82% decline from fiscal 2024.
- AirSculpt Technologies, Inc. revenue from contract with customer, excluding assessed tax for fiscal 2024 was $180.35M, a 7.95% decline from fiscal 2023.
- AirSculpt Technologies, Inc. revenue from contract with customer, excluding assessed tax for fiscal 2023 was $195.92M, a 16.07% increase from fiscal 2022.
- AirSculpt Technologies, Inc. revenue from contract with customer, excluding assessed tax for fiscal 2022 was $168.79M, a 26.61% increase from fiscal 2021.
| Period end | Revenue from Contract with Customer, Excluding Assessed Tax 3 month | Revenue from Contract with Customer, Excluding Assessed Tax 6 month | Revenue from Contract with Customer, Excluding Assessed Tax 9 month | Revenue from Contract with Customer, Excluding Assessed Tax 12 month |
|---|---|---|---|---|
| 2026-06-30 | $42.90M 10-Q · filed 2026-08-10 | $82.29M 10-Q · filed 2026-08-10 | $115.73M derived: sum of 3 quarters · filed 2026-08-10 | $150.72M derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | $39.39M 10-Q · filed 2026-05-08 | $72.83M derived: sum of 2 quarters · filed 2026-05-08 | $107.82M derived: sum of 3 quarters · filed 2026-05-08 | $151.84M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-12-31 | $33.44M derived: 10-K/A 12 month − 10-Q 9 month · filed 2026-04-06 | $68.44M derived: sum of 2 quarters · filed 2026-04-06 | $112.45M derived: sum of 3 quarters · filed 2026-08-10 | $151.82M 10-K/A · filed 2026-04-06 |
| 2025-09-30 | $34.99M 10-Q · filed 2025-11-07 | $79.00M derived: sum of 2 quarters · filed 2026-08-10 | $118.38M 10-Q · filed 2025-11-07 | $157.55M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-06-30 | $44.01M 10-Q · filed 2026-08-10 | $83.38M 10-Q · filed 2026-08-10 | $122.56M derived: sum of 3 quarters · filed 2026-08-10 | $165.11M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | $39.37M 10-Q · filed 2026-05-08 | $78.55M derived: sum of 2 quarters · filed 2026-05-08 | $121.10M derived: sum of 3 quarters · filed 2026-05-08 | $172.10M derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $39.18M derived: 10-K/A 12 month − 10-Q 9 month · filed 2026-04-06 | $81.73M derived: sum of 2 quarters · filed 2026-04-06 | $132.73M derived: sum of 3 quarters · filed 2026-04-06 | $180.35M 10-K/A · filed 2026-04-06 |
| 2024-09-30 | $42.55M 10-Q · filed 2025-11-07 | $93.55M derived: sum of 2 quarters · filed 2025-11-07 | $141.17M 10-Q · filed 2025-11-07 | $188.78M derived: sum of 4 quarters · filed 2026-04-06 |
| 2024-06-30 | $51.00M 10-Q · filed 2025-08-01 | $98.62M 10-Q · filed 2025-08-01 | $146.23M derived: sum of 3 quarters · filed 2026-04-06 | $193.03M derived: sum of 4 quarters · filed 2026-04-06 |
| 2024-03-31 | $47.62M 10-Q · filed 2025-05-02 | $95.23M derived: sum of 2 quarters · filed 2026-04-06 | $142.02M derived: sum of 3 quarters · filed 2026-04-06 | $197.72M derived: sum of 4 quarters · filed 2026-04-06 |
| 2023-12-31 | $47.61M derived: 10-K/A 12 month − 10-Q 9 month · filed 2026-04-06 | $94.40M derived: sum of 2 quarters · filed 2026-04-06 | $150.10M derived: sum of 3 quarters · filed 2026-04-06 | $195.92M 10-K/A · filed 2026-04-06 |
| 2023-09-30 | $46.79M 10-Q · filed 2024-11-08 | $102.50M derived: sum of 2 quarters · filed 2024-11-08 | $148.31M 10-Q · filed 2024-11-08 | $189.01M derived: sum of 4 quarters · filed 2025-03-14 |
| 2023-06-30 | $55.70M 10-Q · filed 2024-08-09 | $101.52M 10-Q · filed 2024-08-09 | $142.22M derived: sum of 3 quarters · filed 2025-03-14 | $181.11M derived: sum of 4 quarters · filed 2025-03-14 |
| 2023-03-31 | $45.81M 10-Q · filed 2024-05-10 | $86.52M derived: sum of 2 quarters · filed 2025-03-14 | $125.41M derived: sum of 3 quarters · filed 2025-03-14 | $175.06M derived: sum of 4 quarters · filed 2025-03-14 |
| 2022-12-31 | $40.70M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-14 | $79.60M derived: sum of 2 quarters · filed 2025-03-14 | $129.25M derived: sum of 3 quarters · filed 2025-03-14 | $168.79M 10-K · filed 2025-03-14 |
| 2022-09-30 | $38.89M 10-Q · filed 2023-11-13 | $88.55M derived: sum of 2 quarters · filed 2023-11-13 | $128.09M 10-Q · filed 2023-11-13 | $165.65M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-06-30 | $49.65M 10-Q · filed 2023-08-11 | $89.20M 10-Q · filed 2023-08-11 | $126.75M derived: sum of 3 quarters · filed 2024-02-27 | $161.41M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-03-31 | $39.54M 10-Q · filed 2023-05-12 | $77.10M derived: sum of 2 quarters · filed 2024-02-27 | $111.75M derived: sum of 3 quarters · filed 2024-02-27 | $146.72M derived: sum of 4 quarters · filed 2024-02-27 |
| 2021-12-31 | $37.56M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $72.21M derived: sum of 2 quarters · filed 2024-02-27 | $107.17M derived: sum of 3 quarters · filed 2024-02-27 | $133.31M 10-K · filed 2024-02-27 |
| 2021-09-30 | $34.65M 10-Q · filed 2022-11-14 | $69.62M derived: sum of 2 quarters · filed 2022-11-14 | $95.76M 10-Q · filed 2022-11-14 | |
| 2021-06-30 | $34.97M 10-Q · filed 2022-08-12 | $61.11M 10-Q · filed 2022-08-12 | ||
| 2021-03-31 | $26.14M 10-Q · filed 2022-05-13 | |||
| 2020-12-31 | $62.77M 10-K · filed 2023-03-10 | |||
| 2019-12-31 | $41.24M 10-K · filed 2022-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LifeMD, Inc. (LFMD) | United States | $0.141B | 982.53 |
| SBC Medical Group Holdings Inc (SBC) | United States | $0.487B | |
| Teladoc Health, Inc. (TDOC) | United States | $1.114B | -8.68 |